A Study of SHR-1701 Plus Platinum-containing Chemotherapy With or Without BP102 (Bevacizumab) as First-line Treatment in Cervical Cancer
Clinical trial NCT05179239 · TERMINATED
Trial details
- NCT number
- NCT05179239
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-26
- Primary completion
- 2024-08-12
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.